Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agenus Inc (NASDAQ:AGEN)

3.83
Delayed Data
As of Feb 23
 +0.03 / +0.79%
Today’s Change
2.65
Today|||52-Week Range
7.49
-7.04%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$330.6M

Company Description

Agenus, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its core technology portfolio consists of Saponin platform and Heat Shock Protein platform. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.

Contact Information

Agenus, Inc.
3 Forbes Road
Lexington Massachusetts 02421-7305
P:(781) 674-4400
Investor Relations:

Employees

Shareholders

Other institutional36.45%
Individual stakeholders25.51%
Mutual fund holders14.30%

Top Executives

Garo H. ArmenChairman & Chief Executive Officer
Christine M. KlaskinVP-Finance & Principal Accounting Officer
Alexander R. DuncanChief Technology Officer
Jean-Marie CuillerotChief Medical Officer
Karen Higgins ValentineSecretary, Chief Compliance Officer & VP